Bio-development | Global Congress

bio-development

Dr. Henry C. Chiou Director of Protein Expression and Transfection Thermo Fisher Scientific

Lada Laenen, Sc.D. VP, Global Head of Manufacturing Sciences and Technology GSK

Tom Spitznagel SVP BioPharmaceutical Development Macrogencs

Dr Aleš Štrancar Managing Director BIA Separations, a Sartorius Company

Alain Bernard VP Tech Operations UCB

BIOLOGICAL MANUFACTURING INNOVATION CAPITALIZED Delivering world class content and connecting business ideas with relationship opportunities to overcome key challenges and innovate breakthroughs in developing next generation biologics and advance therapies

When Great Minds Come Together...

Capitalize On Biological Manufacturing Innovation Ensure technological and operational supremacy and retain success with proven next generation strategies and approaches at Bio-development 2022, Global Congress held in Boston, USA & Worldwide virtually over 2 days. The Bio-development Global Congress is the leading Biological Manufacturing industry forum, exclusively set to help pioneering leaders boost success and growth by providing the perfect modern era networking platform that is highly informative and delivers a dynamic cohesive environment to benchmark, learn, engage, debate, procure and interact at the highest level. Share ideas with dynamic leaders and gain valuable industry knowledge through cohesive closed networking. Converse with innovation that flourishes in biological processing communities, overcoming key challenges, ensuring technological and operational supremacy. Retain success with next generation strategies and approaches, streamlined to obtain seamless integrated success in your biological and novel product development life-cycle, from discovery in the lab to clinical production and commercialization - Innovation in biological production, process development, upstream and downstream.

A compiling program that reflects key strategic issues that senior executives have identified

Intelligence that flourishes within biological process communities.

" Biopharmaceuticals is becoming the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations. "

" Biopharma products are moving from niche to mainstream, the industry is facing a paradigm shift in cost, quality, complexity, and scale. "

Program Chairman & Keynote Speaker Dr Aleš Štrancar, Managing Director BIA Separations,a Sartorius Company

The Bio-development Congress brings you the latest Innovation in Mammalian and Microbial biological Production Strategies and Technologies. The Lastest Key Themes include: Achieving continuous process and product improvement whilst maintaining comparability: Process and product improvement cost reduction strategies throughout manufacturing operations. Fundamental 4.0 evolution to meet quality and process challenges: Implementation of next generation digital Bioprocessing 4.0 and integrating automation technology for Increased GMP compliance and consistency. Enabling acceleration of processing research and scale-up considerations. Advances in purification technologies - Economics and efficiencies Examine new trends in downstream processing, new strategies and approaches to purification of novel and complex molecules, as well as new advances and updates in technologies, equipment and raw materials. integrated upstream and downstream process intensification: Avoid pitfalls and reduce bottlenecks, implementing new breakthrough processing methodologies, technologies and approaches to improve quality, yield and capacity. Optimization of fermentation/cell culture media: Explore next generation Technology, strategies and Innovation that Improves Cell Culture Process Development to increase yield, reduce wastage and consistently produce high quality biological end product. Enable efficient PAT using fast and robust analytical techniques: Enhance Bioprocess understanding that implies a holistic approach to ensure successful QBD. Embracing digital transformation and pioneering high-tech new strategies across the supply chain: Optimizing the supply chain end-to-end to meet the needs of patients and anticipate how to meet their needs tomorrow in a transformational way. Seeing digital and Industry 4.0 technologies as the next driver of innovation and patient-centricity. Ensuring quality management in outsourcing: New approaches to Contract/Outsourcing relationships, project management and methods/technology transfer, reducing delays by setting up clear quality management processes and decision-making plans with CMO's. Cell line development: Accelerating time lines by integrating cell line development and manufacturing programs. Advancements in CHO Cell lines and expression systems for bioproduction. Microbial protein production strategies: The growing trend of increased applications for new protein products. Insight on the latest improvements to microbial expression platforms and protein production systems. High throughput analytics & process development: Techniques to accelerate processing research and scale-up considerations. Implementation of an Adventitious Detection Assay Using High Throughput. Combining data and connecting all process steps together.

Continuous Manufacturing & Process Intensification Autologus Cell Therapy Viral Vectors Scale-up & Tech Transfer Allogeneic Therapy Single Use technology Supply Chain Digital Manufacturing

High Throughput Process Development 4.0 Technology & Automation Stability & Aggregation Analysis Vector Analytics and Characterization QbD & PAT GMP & Compliance

Purification Protein A Capture Viral Clearance Chromatography Extraction Filtration Affinity Resin

Cell Line CHO Expression Perfusion Process Development Cell Culture 3d Technology Optimizing Bio-Reactors Automation

Manufacturing Strategy & Technology Lead

Daniel Fleischanderl Vice President Upstream Processing Boehringer Ingelheim

Kieth Dodson Vice President Business Development AST

Dave Kolwyck VP Manufacturing Science, Raw Materials Biogen

Guilaume Plane Global Development End-to-End Solutions Millipore Sigma

SPEAKERS

70

10

STREAMS

LEADERS

250

HOURS

18

Bio-development participants typically include CEO, CMO, CSO, Vice Presidents, Directors, and Heads of: • Biological Manufacturing • Process Development • Biologics Production • Bio-Processing • Analytical development • Cell Line development • Downstream / Upstream Process Development • 4.0 Technology /Digital Automation • Manufacturing Sciences and Technologies • Operational Excellence • Quality Assurance /Control • Collaborative Manufacturing • Outsourcing manufacturing • Viral Clearance • Purification • Fermentation • Supply Chain • Global Network Management • High Throughput Process Development • Isolation / Extraction • Filtration • PAT & QBD • Capacity Management • Raw material qualification • Technical Operations • Risk management strategies

ATTENDEE PROFILES

65% VP level and above

80% Delegates and Speakers

Modern Era Networking Platform An executive format providing intimate interaction with industry peers, ideas and experiences. The Congress's Unique model is developed and executed by utilizing technological advancements designed particularly to complement networking and communication, implemented exclusively for decision makers to enhance overall experience and provide specialist business information.

Business meetings - Consultative business meetings that focuses on cutting edge solutions to your current initiatives, priorities and future strategic objective.

Thought Provoking Content Globally distinguished speakers and Industry thought leaders providing highly rich Content. Share with fellow leaders and gain priceless industry knowledge, insight and inspiration over two highly informative productive days.

Discussion Groups Interactive round table style sessions on topics which are top of mind issues. Sessions encourage discussion, debate and learning in an unscripted and informal setting.

The Marriott Waterfront Hotel, Boston will host The bio-development Global Congress 2022. The World class venue provides the perfect ambiance for leaders to congregate, bringing together the smartest people to share their experience, ideas, innovations and expertise. Access the right intelligence to design your future with robust strategies in confidence.

A major global hub, Boston has a unique Biopharma DNA and culture; one that is collaborative in nature

Email: Enter Email

Submitting Form...

The server encountered an error.

Innovate World Class speaker with the highest Credentials delivering unrivaled insight make up our compiling programs, if you would like to present to an interactive audience of pioneering industry leaders please contact

Collaborate Our summits are specially designed for company elites and span the entire Pharmaceutical and Life Science realm. For group bookings or an annual global members pass card please contact

Advance Market leader with cutting edge capabilities present great innovation. If end users gain a distinct advantage by using your product or services please contact

Delegates Inquisitions.

© 2022 All rights reserved. Weiser West, The Shard, 26th Floor, 32 London Bridge Street, London SE1 9SG